#1 Clinical Trials Search in Europe

Clemastine

Clemastine, an antihistamine medication, is being investigated in several clinical trials for its potential remyelinating effects in conditions like multiple sclerosis and optic neuritis. Researchers are exploring whether clemastine can help repair damaged myelin in the central nervous system, potentially improving neurological function and slowing disease progression. These trials aim to assess clemastine’s efficacy, safety, and tolerability as a novel therapeutic approach for demyelinating disorders.

Table of Contents

What is Clemastine?

Clemastine, also known by brand names such as Tavist, Dayhist, and Dayhist Allergy, is a medication that was originally approved by the Food and Drug Administration (FDA) for treating allergies[1]. It belongs to a class of drugs called antihistamines, which help relieve allergy symptoms. However, recent research has shown that clemastine may have potential benefits beyond treating allergies, particularly in neurological conditions like multiple sclerosis (MS)[2].

Potential Uses of Clemastine

While clemastine is not yet FDA-approved for these uses, researchers are investigating its potential in treating several conditions:

  • Multiple Sclerosis (MS): Clemastine is being studied as a potential treatment for various forms of MS, including relapsing-remitting MS, primary progressive MS, and chronic progressive MS[1].
  • Optic Neuritis: This is an inflammation of the optic nerve that can cause vision loss. Researchers are investigating if clemastine can help repair damage to the optic nerve[3].
  • Late-life Depression: Some studies are looking at whether clemastine can improve brain function and boost antidepressant response in older adults with depression[4].
  • Williams Syndrome: This is a rare genetic disorder that affects various parts of the body. Researchers are studying if clemastine can help with neurodevelopmental delays associated with this condition[5].

How Clemastine Works

In MS and similar conditions, clemastine is thought to work by promoting remyelination. Myelin is a protective coating around nerve fibers in the brain and spinal cord. In MS, this coating is damaged, leading to various symptoms. Clemastine may help by:

  • Promoting Oligodendrocyte Differentiation: Oligodendrocytes are cells that produce myelin. Clemastine may help these cells mature and produce more myelin[2].
  • Improving White Matter Integrity: White matter in the brain consists largely of myelinated nerve fibers. Researchers are using advanced brain imaging techniques to see if clemastine can improve the structure and function of white matter[1].

Clinical Trials and Research

Several clinical trials are currently underway to investigate the potential benefits of clemastine:

  • MS and Optic Neuritis: Trials are looking at whether clemastine can improve visual function in people with MS-related optic nerve damage[3].
  • Brain Imaging Studies: Researchers are using advanced MRI techniques to see if clemastine can improve various measures of brain health in people with MS[1].
  • Depression in Older Adults: A study is investigating whether clemastine can improve brain function and enhance the effects of antidepressants in older adults with depression[4].
  • Williams Syndrome: Researchers are studying if clemastine can help improve cognitive, motor, and social skills in children with Williams syndrome[5].

Potential Side Effects

As with any medication, clemastine may cause side effects. Common side effects of antihistamines like clemastine can include:

  • Drowsiness or sleepiness
  • Dizziness
  • Dry mouth
  • Headache
  • Stomach discomfort

In the clinical trials for MS and other conditions, researchers are carefully monitoring for any side effects, particularly fatigue, as this is already a common symptom in MS[1].

Other Potential Uses

In addition to the neurological conditions mentioned above, researchers are also investigating clemastine for other potential uses:

  • Cardiovascular Surgery: A study is looking at whether clemastine can help reduce allergic reactions during heart surgery[6].
  • Cancer Treatment: Researchers are studying whether clemastine can help prevent allergic reactions to certain chemotherapy drugs[7].

It’s important to note that while these studies show promise, clemastine is not yet approved for treating MS or any of these other conditions. Patients should always consult with their healthcare provider before considering any new treatment.

Aspect Details
Drug Clemastine Fumarate
Primary Conditions Studied Multiple Sclerosis, Optic Neuritis, Internuclear Ophthalmoparesis
Potential Mechanism Remyelination of damaged nerve fibers
Main Outcome Measures Visual Evoked Potentials, MRI measures (Myelin Water Fraction, T1 Relaxation Time), Clinical disability scales
Dosages Tested Varying by study, e.g. 4-12 mg daily
Treatment Duration Typically 3-6 months
Study Designs Randomized, double-blind, placebo-controlled trials
Safety Monitoring Adverse event tracking, fatigue assessments
Additional Applications Late-life depression, Williams Syndrome

FAQ

  • What is clemastine and why is it being studied in clinical trials? Clemastine is an antihistamine medication that is being studied for its potential remyelinating effects. Researchers have found that clemastine may help promote the repair of damaged myelin in the central nervous system, which could benefit patients with conditions like multiple sclerosis and optic neuritis.
  • What are some of the main conditions being targeted in clemastine clinical trials? The main conditions being targeted in clemastine clinical trials include multiple sclerosis (MS), optic neuritis, internuclear ophthalmoparesis, and other demyelinating disorders affecting the central nervous system. Some trials are also looking at its potential in Williams syndrome and late-life depression.
  • How is clemastine's effectiveness being measured in these trials? Clemastine's effectiveness is being measured through various methods, including MRI techniques to assess myelin integrity, visual evoked potentials to evaluate optic nerve function, clinical assessments of neurological symptoms, and cognitive/functional tests. Specific measures include myelin water fraction, T1 relaxation time, and various visual and motor function tests.
  • What are some of the potential benefits being investigated for clemastine? Potential benefits being investigated for clemastine include improved myelin repair and integrity, enhanced visual function in optic neuritis, reduced disability progression in MS, improved cognitive function, and better overall neurological outcomes in demyelinating conditions. Some studies are also looking at its effects on depression symptoms and neurodevelopment.
  • Are there any known side effects or safety concerns with clemastine in these trials? While clemastine is generally considered safe as an antihistamine, the trials are closely monitoring for any adverse effects. Common side effects may include drowsiness and dry mouth. The studies include assessments of tolerability and safety, with particular attention to fatigue levels, as fatigue can be a significant symptom in conditions like multiple sclerosis.

Ongoing Clinical Trials on Clemastine

  • Study on Clemastine and Aerobic Exercise for Improving Cognitive Function in Schizophrenia Patients

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study to Compare Non-Radioactive Methods for Measuring Kidney Function in Patients with Chronic Kidney Disease Using Sodium Iotalamate, Sodium Iodohippurate, and Iohexol

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Clemastine and Fampridine for Patients with Multiple Sclerosis and Internuclear Ophthalmoparesis

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on BI-1910 and Pembrolizumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1
    Investigated drugs:
    Denmark Germany Poland Spain Sweden

Glossary

  • Myelin: A fatty substance that surrounds and insulates nerve fibers, helping to transmit electrical signals quickly and efficiently in the nervous system.
  • Remyelination: The process of repairing damaged myelin sheaths around nerve fibers, which may help restore neurological function in demyelinating diseases.
  • Multiple Sclerosis (MS): A chronic neurological disease in which the immune system attacks the protective myelin sheath covering nerve fibers, leading to communication problems between the brain and the rest of the body.
  • Optic Neuritis: Inflammation of the optic nerve that can cause sudden vision loss, often associated with multiple sclerosis.
  • Internuclear Ophthalmoparesis: A disorder of eye movement caused by a lesion in the brainstem, often seen in multiple sclerosis patients.
  • Visual Evoked Potential (VEP): A test that measures the electrical activity in the brain in response to visual stimuli, used to assess optic nerve function.
  • Magnetic Resonance Imaging (MRI): A medical imaging technique that uses magnetic fields and radio waves to create detailed images of organs and tissues in the body.
  • Myelin Water Fraction (MWF): A measure derived from MRI that estimates the amount of myelin in brain tissue.
  • T1 Relaxation Time: An MRI parameter that can provide information about tissue microstructure and myelin content.
  • Expanded Disability Status Scale (EDSS): A method of quantifying disability in multiple sclerosis and monitoring changes over time.

References

  1. https://clinicaltrials.gov/study/NCT05359653
  2. https://clinicaltrials.gov/study/NCT02040298
  3. https://clinicaltrials.gov/study/NCT02521311
  4. https://clinicaltrials.gov/study/NCT06591091
  5. https://clinicaltrials.gov/study/NCT06315699
  6. https://clinicaltrials.gov/study/NCT03826004
  7. https://clinicaltrials.gov/study/NCT06039137